These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2015598)

  • 1. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole.
    Curtin NJ; Harris AL; Aherne GW
    Cancer Res; 1991 May; 51(9):2346-52. PubMed ID: 2015598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition.
    Webley SD; Welsh SJ; Jackman AL; Aherne GW
    Br J Cancer; 2001 Aug; 85(3):446-52. PubMed ID: 11487279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of quinazoline antifolate (CB3717) toxicity by dipyridamole in human lung carcinoma, A549, cells.
    Curtin NJ; Harris AL
    Biochem Pharmacol; 1988 Jun; 37(11):2113-20. PubMed ID: 3377815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate.
    Canman CE; Lawrence TS; Shewach DS; Tang HY; Maybaum J
    Cancer Res; 1993 Nov; 53(21):5219-24. PubMed ID: 8221659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
    Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
    Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of dipyridamole action by alpha 1 acid glycoprotein. Reduced potentiation of quinazoline antifolate (CB3717) cytotoxicity by dipyridamole.
    Curtin NJ; Newell DR; Harris AL
    Biochem Pharmacol; 1989 Oct; 38(19):3281-8. PubMed ID: 2818627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor.
    Yin MB; Guimaraes MA; Zhang ZG; Arredondo MA; Rustum YM
    Cancer Res; 1992 Nov; 52(21):5900-5. PubMed ID: 1394217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid.
    Lorico A; Toffoli G; Boiocchi M; Erba E; Broggini M; Rappa G; D'Incalci M
    Cancer Res; 1988 Apr; 48(8):2036-41. PubMed ID: 3349474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines.
    Smith PG; Marshman E; Calvert AH; Newell DR; Curtin NJ
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):63-7. PubMed ID: 10598557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
    Fisher TC; Milner AE; Gregory CD; Jackman AL; Aherne GW; Hartley JA; Dive C; Hickman JA
    Cancer Res; 1993 Jul; 53(14):3321-6. PubMed ID: 8324744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse.
    Newell DR; Alison DL; Calvert AH; Harrap KR; Jarman M; Jones TR; Manteuffel-Cymborowska M; O'Connor P
    Cancer Treat Rep; 1986 Aug; 70(8):971-9. PubMed ID: 3731153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J; Hedley DW; Erlichman C
    Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport.
    Smith PG; Marshman E; Newell DR; Curtin NJ
    Br J Cancer; 2000 Feb; 82(4):924-30. PubMed ID: 10732767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
    Koehler SE; Ladner RD
    Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.